Last update 23 Nov 2024

GLG-801

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
GLG 801
Target
STAT3
Mechanism
STAT3 inhibitors(Signal transducer and activator of transcription 3 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Chronic Lymphocytic Leukemia
Inactive Indication
Breast CancerPolycystic Kidney Diseases
Originator Organization
H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
Active Organization
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.H. Lee Moffitt Cancer Center & Research Institute, Inc.
Inactive Organization
GLG Pharma SA
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with GLG-801
EUCTR2017-005057-36-PL / Unknown statusPhase 1/2
A Phase I/II Open-Label Study to Evaluate the Safety, Tolerability and Recommended Phase II Dose (RP2D) of GLG-801 in patients with Advanced Solid Tumors (Phase I); and safety, tolerability and anticancer activity of GLG-801 in patients with Metastatic TNBC (Phase II).
100 Clinical Results associated with GLG-801
Login to view more data
100 Translational Medicine associated with GLG-801
Login to view more data
100 Patents (Medical) associated with GLG-801
Login to view more data
100 Deals associated with GLG-801
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 2
PL
GLG Pharma SA
07 Jun 2018
Chronic Lymphocytic LeukemiaPhase 2
PL
GLG Pharma SA
17 Nov 2015
Polycystic Kidney DiseasesPreclinical
PL
GLG Pharma SA
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free